Will Roberts | Investor Relations and Corporate Communications |
Armando Anido | Chairman and Chief Executive Officer |
Jim Fickenscher | Chief Financial Officer and Vice President of Corporate Development |
Good morning and welcome to the Zynerba Pharmaceuticals’ Second Quarter 2018 Business Update Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.
As a remainder, today's conference call is being recorded. I would now like to turn the call over to Will Roberts, Vice President, Investor Relations and Corporate Communications.